Vertex Ventures Leads ~USD14m Angel Round for China’s PrimeLink
Source(s): 36Kr
Vertex Ventures led a ~CNY100(~USD14m) angel round for PrimeLink, a China-based developer of antibody drug conjugates, with participation from Kaitai Capital and Fosun Pharma. Read more